pharmaceutical litigation attorney

Recent evidence links the popular heartburn medication to an increased cancer risk, thus FDA demands Zantac recall. The agency wants all ranitidine off store shelves effective immediately. Currently, the Food and Drug Administration is sending letters to Sanofi and other ranitidine manufactures asking them to stop making and shipping product. Additionally, the FDA advises consumers…Read the article

Over-the-counter Zantac (Ranitidine) is already one of the largest-selling antacids in the United States. Annual revenue exceeds $125 million. That market share was expected to triple by 2026. Then, the Food and Drug Administration found a dangerously-high level of a cancer-causing compound in Zantac. The watchdog then ordered Sanofi to stop selling the drug in…Read the article

The Food and Drug Administration told over a dozen companies to stop selling cannabidiol-infused food products and stop making inflated health claims about their products. CBD is a non-psychoactive marijuana ingredient which has medicinal properties. Yet the FDA has only approved one CBD product. Epidiolex treats some rare forms of childhood epilepsy. Other CBD products,…Read the article

The U.S. Food and Drug Administration’s voluntary blood pressure drug recall continues as Torrent Pharmaceuticals Limited announced it is expanding its nationwide recall to include two blood pressure medications that were found to contain trace amounts of a potential cancer-causing carcinogen. The two medications are 3 lots of Losartan Potassium Tablets USP and 2 lots…Read the article

You Are What You Eat High sodium and low potassium diets may contribute to teenage depression, according to a new study. This finding may impact both patients and providers. Such a diet indicates many processed foods and few fresh fruits and vegetables. Researchers at the University of Alabama-Birmingham found a conclusive link between depression and…Read the article

If you caught our last article, What You Need to Know About Taxotere, the experienced pharmaceutical litigation team at Napoli Shkolnik PLLC explored what Taxotere is and why it is a dangerous pharmaceutical linked to permanent hair loss in breast cancer survivors treated with this drug. In short, Taxotere is an FDA-approved chemotherapy drug that…Read the article

More than 265,000 new cases of breast cancer are diagnosed. Despite sharing one name, there are several different types of breast cancers that develop in different parts of the breast and affect specific cells. Despite the numbers of new diagnoses and the myriad of different types, new treatments are becoming ever more effective, resulting in…Read the article

Chemotherapy has proven to be an effective way to combat the signs, symptoms, and effects of a wide variety of cancers, including breast cancer. When used, chemotherapy can increase the chance of a cure, reduce the likelihood that cancer will return, and can help breast cancer patients live a longer life. However, this treatment is…Read the article

In 2018, there were approximately 266,120 new cases reported of invasive types of breast cancer, along with another 63,960 cases reported of non-invasive types of breast cancer. For every eight women in the United States, at least one will develop some form of breast cancer over the course of her lifetime. These numbers are simply…Read the article

The U.S. Food and Drug Administration (FDA) issued a warning in late August 2018 about the link between diabetic medications and a rare, yet life-threatening disease called Fournier’s gangrene. The warning is specific to certain FDA-approved inhibitors (SGLT2), which are said to prevent the kidneys from reabsorbing sugar into the blood, therefore helping lower blood…Read the article